False patent marking: a trap for the unwary patentee

To view this article you need a PDF viewer such as Adobe Reader.

USA January 5 2009

Fitzpatrick, Cella, Harper & Scinto - This article first appeared in IAM magazine. For further information please visit <a target="_blank" href="http://www.iam-magazine.com/">www.iam-magazine.com</a> <br />  <br /> 

Save & file
View original
Forward
Share
Follow
Please login to follow content.
Like

Filed under

USA
Intellectual Property
Litigation
Fitzpatrick, Cella, Harper & Scinto

Register now for your free, tailored, daily legal newsfeed service.

False patent marking: a trap for the unwary patentee

Filed under

Popular articles from this firm

Amgen Obtains $70 Million Damages Award Against Hospira For Infringement Of Amgen’s Erythropoetin Patent *

Amgen obtains $70 million damages award against Hospira for erythropoietin patent infringement *

Federal Circuit Clarifies Venue Issues In Patent Cases *

Federal Circuit Suggests That “Insubstantial Differences” Test May Be More Suitable Than “Function-Way-Result” Test For Evaluating Equivalence In Chemical Patent Cases *

'Repeat infringers' under Digital Millennium Copyright Act not repeat infringers as adjudged by court *

Related topic hubs

Lexology Navigator Q&A

Compare jurisdictions:Litigation: Enforcement of Foreign Judgments